Abstract
Lymph node metastases (LNM) are present in a minority of patients with early stages of cervical carcinomas. As conventional imaging including PET/CT has shown limited sensitivity, systematic lymphadenectomies are often conducted for staging purposes. Therefore, the aim of this prospective study was to analyze the impact of 18F-FDG PET/MRI in addition to sentinel node (SLN) biopsy on lymph node status. Methods: 42 women with initial diagnosis of FIGO IA-IIB cervical carcinomas were included between 03/2016–04/2019. Each patient received preoperative whole body 18F-FDG PET/MRI (Biograph mMR®, Siemens Healthineers) and SLN imaging with SPECT/CT (Discovery 670 Pro®, GE Healthcare) after intracervical injection of 99mTc-labeled nanocolloid. Systematic Lymphadenectomy and SLN biopsy served as reference standard. Staging in PET/MRI was performed as a consensus of nuclear medicine and radiology experts. Results: One patient was excluded from surgical staging due to newly diagnosed liver metastases in PET/MRI. Overall prevalence of LNM in the remaining 41 patients was 29.3% (12/41). 5/12 patients with LNM solely had small metastases with maximum diameter ≤5mm. Interpretation of PET/MRI as a consensus of experts showed a specificity of 100% (29/29, 95%CI: 88.3-100%) for LNM-staging, but a low sensitivity of 33.3% (4/12, 95%CI: 12.8-60.9%). LN size was the most important factor for the detectability of metastases, since only LNM >5mm could be identified by PET/MRI (sensitivity >5mm: 57.1%; ≤5mm: 0%). Paraaortic LNM were evaluated accurately in 3/4 cases (16 patients with paraaortic LN removal). SLNs were detectable by SPECT/CT in 82.9% of the patients or 69.0% of hemipelvis. In cases with undetectable SLN in SPEC/TCT, malignancy rate was considerably higher (31.2% vs. 19.3%). The combination of PET/MRI and SLN SPECT/CT improved the detection of pelvic LNM from 33.3% to 75%. Conclusion: 18F-FDG PET/MRI is a highly specific N-staging method and improves LNM detection. Due to the limited sensitivity in frequently occurring small LNM, PET/MRI should be combined with sentinel node mapping. The proposed combined protocol helps to decide whether extensive surgical staging is necessary in patients with FIGO I/II cervical cancer.
- Oncology: GYN
- PET/MRI
- SPECT/CT
- 18F-FDG PET/MRI
- 99mTc-nanocolloid SPECT/CT
- cervical carcinoma
- combined protocol
- sentinel node
- Copyright © 2021 by the Society of Nuclear Medicine and Molecular Imaging, Inc.
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
SNMMI members
Login to the site using your SNMMI member credentials
Individuals
Login as an individual user